Navigation Links
Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
Date:12/9/2008

or acute agitation: speed of onset, reliability of medication delivery and patient preference. The Company believes AZ-004 is a product candidate that has the potential to be the first product, if approved, that would be able to both meet these needs for most agitation sufferers and allow physicians to effectively respond to the potential rapid escalation of an acute agitation episode.

About AZ-004 (Staccato loxapine)

AZ-004 is the combination of Alexza's proprietary Staccato system with loxapine, a drug belonging to the class of compounds known generally as antipsychotics. The Staccato system is a hand-held, chemically-heated, single dose inhaler designed to generate and deliver excipient-free drug aerosol for deep lung delivery that results in IV-like pharmacokinetics. Alexza has now completed five clinical trials with AZ-004, enrolling more than 800 patients, and has announced positive results from all of these studies.

These five studies include a 50 subject Phase 1 study in healthy volunteers, a 129 patient Phase 2 study in agitated schizophrenic patients, a 32 patient multiple-dose tolerability and pharmacokinetic study in non-agitated schizophrenic patients, a 344 patient Phase 3 study in schizophrenic patients with acute agitation, and a 314 patient Phase 3 study in bipolar disorder patients with acute agitation. Alexza completed an end- of-Phase 2 meeting with the FDA for AZ-004 in September 2007, and believes it has a clear understanding of the development requirements for filing an NDA for AZ-004.

In the previously reported Phase 3 study in agitated schizophrenic patients, both the 5 mg and 10 mg doses of AZ-004 met the primary endpoint of the trial and the key secondary endpoint of the trial, both doses showing a highly statistically significant reduction in agitation in both endpoints, as compared to placebo. The 10 mg dose of AZ-004 exhibited a rapid onset of effect, w
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
2. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
3. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
4. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
5. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
8. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
11. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... 27, 2014 Sinovac Biotech Ltd. (NASDAQ: SVA ... , today announced the results of the Company,s 2014 Annual ... Beijing , PRC. The required quorum, a majority ... The Company,s shareholders approved the following proposals:  , ... , Simon Anderson , Kenneth Lee and ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2
... provide first real-time analysis of such ... infectious-disease outbreaks, ... its kind, infectious-disease-modeling experts at Fred,Hutchinson Cancer Research Center confirm ... a small number of people within a family in,Indonesia. The ...
... Journal Nature Medicine, CLEVELAND, Aug. 27 ... mechanism that accounts for platelet hyper-responsiveness,during abnormal ... for fatal,heart attacks and strokes. In ... Podrez, M.D., Ph.D., of,Cleveland Clinic,s Lerner Research ...
Cached Medicine Technology:Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006 2Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006 3Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006 4Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation 2Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation 3
(Date:8/27/2014)... August 27, 2014 As medical marijuana ... big business has taken notice. With 23 states and ... cannabis friendly legislation on their books the time for ... as New York and Florida are in the process ... laws a void of reliable information and services has ...
(Date:8/27/2014)... Chicago, Illinois (PRWEB) August 27, 2014 ... the 2014 FIBA World Cup in Spain at ... in their role as FIBA Equipment & Venue Centre Partner ... to 2016. , The six courts will bear the Connor ... by fans around the globe on the ESPN broadcasts of ...
(Date:8/27/2014)... Ontario (PRWEB) August 27, 2014 When Jagger ... a call from his mother; one that he credits as ... received. His mom had news that she could set him ... supporting people with disabilities. Jagger took that job, and he ... disabled. Throughout these past two decades, he also worked in ...
(Date:8/27/2014)... Overconfident people are better at convincing others that they,re ... more likely to get promotions and reach high-level positions, ... these "self-deceived" people are also more likely to overestimate ... And finally, people who underestimate themselves are regarded as ... researchers. Their findings were published Aug. 27 in the ...
(Date:8/27/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Oko, Dr. Yanina Meshko and Dr. Nana Yenukashvili ... experienced physicians comprise CarePoint Health Medical Group, a ... Hudson County, representing a wide range of specialties. ...
Breaking Medicine News(10 mins):Health News:The Marijuana Real Estate Market Opens Up 2Health News:The Marijuana Real Estate Market Opens Up 3Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3
... USA, the leading generic pharmaceutical company, today released ... part of the "Year of Affordable Healthcare" campaign.The ... www.yearofaffordablehealth.com/gallery ) is meant to illustrate the important ... since the passage of Waxman-Hatch 25 years ago. ...
... Texas, Feb. 24 The Texas Association of Health,Underwriters ... the Capitol on,March 2, 2009 at the Sheraton Hotel ... to network and discuss client issues with other agents,and ... a panel discussion featuring political blogger from,InThePinkTaxas.com and editor ...
... recent weeks, a number of childhood deaths across the country ... importance of preventing this serious and sometimes deadly disease with ... influenza activity at a relatively high level across the country, ... the vaccine to do so. It takes about two weeks ...
... BEACH, Fla., Feb. 24 Today Sentry Data ... Platform to independent solution providers. The Datanex(TM) ... that allows solution providers to construct rich healthcare ... the world,s fastest and most comprehensive healthcare data ...
... Feb. 24 Solos Endoscopy, Inc. (Pink Sheets: ... Breast Endoscopy System, the MammoView(TM), was featured in ... in the January 2009 issue. The article focused ... detect breast cancer earlier, with minimally invasive ductoscopy. ...
... After a successful showing at the 2009,South Beach ... it,has officially hit over 300 stores in South Florida ... the recently opened accounts include: CVS on Lincoln Road,Miami ... Palm Beach;,Presidente Markets, Tom Thumb, Penn Dutch, Quick Stop, ...
Cached Medicine News:Health News:Texas Association of Health Underwriters Announces 15th Annual Day at the Capitol 2Health News:Recently Reported Childhood Deaths from Influenza Are a Stark Reminder to Vaccinate Now 2Health News:Sentry Data Systems Announces Interoperative Healthcare Cloud Computing Platform 2Health News:Sentry Data Systems Announces Interoperative Healthcare Cloud Computing Platform 3Health News:Solos Endoscopy, Inc.'s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine 2Health News:Next Generation Waters Successfully Reaches Over 300 Stores! 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: